noscript

News and Announcements

CAVATAK™ bladder cancer positive preliminary data

  • Published November 29, 2012 4:01PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Source: ASX and Media Release

Viralytics Limited (ASX:VLA, OTC:VRACY) has received positive preliminary data in bladder cancer in its collaboration with Professor Hardev Pandha’s research team at The University of Surrey in the United Kingdom.

Viralytics to endeavour to also target bladder cancer application with melanoma, lung and prostate cancer.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now